Skip to main
CAPR
CAPR logo

Capricor Therapeutics (CAPR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Capricor Therapeutics (CAPR) Stock

About Capricor Therapeutics (CAPR)

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered ...read more
Market cap$538.44M
Today's volume1.2M
Revenue (TTM)$17.36M
Avg. daily volume2.16M
EBITDA (TTM)-$55.78M
Open$12.11
Price / earnings ratio-8.30x
Today's range$11.83 - $12.4
Debt / equity3.62x
52 week range$3.52 - $23.4
5 year debt / equity19.93x
Beta (LTM)1.25x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio6.55x
Ex-dividend date
Next earningsAug 6, 2025
Dividend payable date

Capricor Therapeutics Stock Rating

What analysts recommend for CAPR stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for CAPR stock is $538.44M

The current P/E ratio for CAPR stock is -8.3

The 52-week high for CAPR stock is $23.40. The current CAPR stock price $undefined is 100.00% below its 52-week high

The 52-week low for CAPR stock is $3.52. The current CAPR stock price $undefined has increased 100.00% from its 52-week low

No, the CAPR stock does not pay dividends to its shareholders

The target price for CAPR stock is $36.12 based on the average of what a group of analyst think CAPR stock could be worth at a future date. This is not a prediction by Public.com

How to buy CAPR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CAPR stock

    Navigate to the Explore page. Then, type CAPR into the search bar. When you see CAPR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CAPR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Capricor Therapeutics Stock Earnings

The value each CAPR share was expected to gain vs. the value that each CAPR share actually gained.

Capricor Therapeutics (CAPR) reported Q1 2025 earnings per share (EPS) of -$0.53, missing estimates of -$0.32 by 65.63%. In the same quarter last year, Capricor Therapeutics's earnings per share (EPS) was -$0.31. Capricor Therapeutics is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of $0.

Buy Capricor Therapeutics (CAPR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.